Edition:
United Kingdom

Bionano Genomics Inc (BNGO.OQ)

BNGO.OQ on NASDAQ Stock Exchange Capital Market

6.99USD
8:59pm GMT
Change (% chg)

$-0.06 (-0.85%)
Prev Close
$7.05
Open
$6.70
Day's High
$6.99
Day's Low
$6.70
Volume
575
Avg. Vol
--
52-wk High
$10.00
52-wk Low
$6.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 2.83 -0.330
Jun '18 3.39 -0.222
Mar '18 1.77 -0.258
FY 2017 Dec '17 9.51 -1.566
Sep '17 2.74 -0.341
Jun '17 2.20 -0.447
Mar '17 1.72 -0.381
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 3.34 3.71 2.97 --
Quarter Ending Mar-19 2 2.25 2.41 2.08 --
Year Ending Dec-18 2 11.45 11.69 11.22 --
Year Ending Dec-19 2 14.84 16.10 13.58 --
Earnings (per share)
Quarter Ending Dec-18 2 -0.43 -0.37 -0.48 --
Quarter Ending Mar-19 1 -0.48 -0.48 -0.48 --
Year Ending Dec-18 2 -2.24 -1.72 -2.76 --
Year Ending Dec-19 2 -1.30 -1.16 -1.45 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 195.28 33.64
P/E High - Last 5 Yrs. -- 74.87 45.61
P/E Low - Last 5 Yrs. -- 20.41 23.70
Beta -- 0.94 0.88
Price to Sales (TTM) -- 8.44 5.95
Price to Book (MRQ) -- 4.01 4.89
Price to Tangible Book (MRQ) -- 5.40 6.50
Price to Cash Flow (TTM) -- 17.29 22.90
% Owned Institutions -- 18.45 2.15

Dividends

  Company industry sector
Dividend Yield -- 0.78 1.51
Dividend Yield - 5 Year Avg -- 0.66 1.52
Dividend 5 Year Growth Rate -- 6.40 5.41
Payout Ratio(TTM) -- 22.51 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 12.97 8.08
Sales (TTM) vs TTM 1 Yr. Ago -- 6.24 5.80
Sales - 5 Yr. Growth Rate -- 3.03 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 43.62 23.27
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 3.96 10.88
Capital Spending - 5 Yr. Growth Rate -- 10.67 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.69 2.27
Current Ratio (MRQ) -- 2.20 3.07
LT Debt to Equity (MRQ) -- 41.84 13.15
Total Debt to Equity (MRQ) -- 52.59 17.74
Interest Coverage (TTM) -- 19.52 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.81 54.86
Gross Margin - 5 Yr. Avg. -- 55.84 52.38
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 15.72 10.90
Operating Margin (TTM) -- -1.17 3.24
Operating Margin - 5 Yr. Avg. -- 7.37 6.22
Pre-Tax Margin (TTM) -- -0.39 4.31
Pre-Tax Margin - 5 Yr. Avg. -- 6.54 6.66
Net Profit Margin (TTM) -- -2.30 0.58
Net Profit Margin - 5 Yr. Avg. -- 4.50 2.90
Effective Tax Rate (TTM) -- 15.83 23.26
Effective Tax Rate - 5 Yr. Avg. -- 20.91 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 16,205,798 803,310,882
Net Income/Employee (TTM) -- 1,433,065 94,478,474
Receivable Turnover (TTM) -- 5.50 5.78
Inventory Turnover (TTM) -- 4.36 3.71
Asset Turnover (TTM) -- 0.79 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 1.24 10.86
Return on Assets - 5 Yr. Avg. -- 4.54 11.96
Return on Investment (TTM) -- 9.64 14.22
Return on Investment - 5 Yr. Avg. -- 6.17 15.54
Return on Equity (TTM) -- 15.60 15.99
Return on Equity - 5 Yr. Avg. -- 9.71 16.82
Note: Units in Millions of US Dollars

Performance for Bionano Genomics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 73.26%
# of Holders: 5
Total Shares Held: 7,349,538
3 Mo. Net Change: 7,349,538
# New Positions: 5
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 0
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.